Cargando…
KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery
A deficient activity of one or more of the mitochondrial oxidative phosphorylation (OXPHOS) enzyme complexes leads to devastating diseases, with high unmet medical needs. Mitochondria, and more specifically the OXPHOS system, are the main cellular production sites of Reactive Oxygen Species (ROS). I...
Autores principales: | Beyrath, Julien, Pellegrini, Mina, Renkema, Herma, Houben, Lisanne, Pecheritsyna, Svetlana, van Zandvoort, Peter, van den Broek, Petra, Bekel, Akkiz, Eftekhari, Pierre, Smeitink, Jan A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920042/ https://www.ncbi.nlm.nih.gov/pubmed/29700325 http://dx.doi.org/10.1038/s41598-018-24900-3 |
Ejemplares similares
-
Sonlicromanol’s active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth
por: Jiang, Xiaolan, et al.
Publicado: (2021) -
Mechanism of action and potential applications of selective inhibition of microsomal prostaglandin E synthase-1-mediated PGE(2) biosynthesis by sonlicromanol’s metabolite KH176m
por: Jiang, X., et al.
Publicado: (2021) -
Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease
por: de Haas, Ria, et al.
Publicado: (2017) -
KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers
por: Koene, Saskia, et al.
Publicado: (2017) -
The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury
por: Xiao, Yang, et al.
Publicado: (2021)